Back to top
more

AnheuserBusch InBev (BUD)

(Delayed Data from NYSE)

$61.35 USD

61.35
2,076,928

+1.03 (1.71%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $61.37 +0.02 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 17% (204 out of 246)

Industry: Beverages - Alcohol

Zacks News

Zacks Equity Research

AB InBev Stock Progresses Well on Premiumization & Expansion Strategy

BUD's premiumization strategy looks good. It is gaining from robust consumer demand for its megabrands.

Zacks Equity Research

Constellation Brands Q4 Earnings to Show Mixed Trends: Should You Buy?

STZ's Q4 results are expected to reflect headwinds in wine & spirits, and inflationary pressures. Meanwhile, its beer segment stays strong, driving growth.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Why Anheuser-Busch Inbev (BUD) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

The Zacks Analyst Blog Philip Morris, Booking Holdings, Anheuser-Busch InBev, Elite Pharmaceuticals and National Research

Philip Morris, Booking Holdings, Anheuser-Busch InBev, Elite Pharmaceuticals and National Research are included in this Analyst Blog.

Mark Vickery headshot

Top Stock Reports for Philip Morris, Booking Holdings & Anheuser-Busch

Today's Research Daily features new research reports on 16 major stocks, including Philip Morris International Inc. (PM), Booking Holdings Inc. (BKNG) and Anheuser-Busch InBev SA/NV (BUD), as well as two micro-cap stocks Elite Pharmaceuticals, Inc. (ELTP) and National Research Corp. (NRC).

Zacks Equity Research

AB InBev Shares Up 26.2% in Past 3 Months: Should You Hold or Sell?

BUD's premiumization strategy looks good. It is gaining from robust consumer demand for its megabrands.

Zacks Equity Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

KNBWY vs. BUD: Which Stock Is the Better Value Option?

KNBWY vs. BUD: Which Stock Is the Better Value Option?

Zacks Equity Research

AB InBev Q4 Earnings & Revenues Beat, Global Beer Momentum Continues

BUD's Q4 results reflect the continued global strength of its beer portfolio, with notable growth in Beyond Beer offerings and its above-core brands.

Zacks Equity Research

Markets Await New Home Sales Data

Markets Await New Home Sales Data

Mark Vickery headshot

Pre-Markets Try, Try Again to Break into Green

All indexes are still up year to date besides the Russell, although the Nasdaq is hanging on by less than a percentage point.

Zacks Equity Research

Here's What Key Metrics Tell Us About Anheuser-Busch Inbev (BUD) Q4 Earnings

The headline numbers for Anheuser-Busch Inbev (BUD) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

The Zacks Analyst Blog Highlights Keurig Dr Pepper, Boston Beer, Anheuser-Busch, Monster Beverage and Fomento Economico Mexicano

Keurig Dr Pepper, Boston Beer, Anheuser-Busch, Monster Beverage and Fomento Economico Mexicano are included in this Analyst Blog.

Mark Vickery headshot

Top Research Reports for Alibaba, Pfizer & MercadoLibre

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE) and MercadoLibre, Inc. (MELI), as well as a micro-cap stock SIFCO Industries, Inc. (SIF).

Zacks Equity Research

Are These 5 Beverage Stocks Poised for Earnings Beat This Season?

The beverage industry players are expected to have gained from expansion, pricing and solid demand, but inflation and currency woes are likely to have posed challenges.

Zacks Equity Research

AB InBev's Q4 Earnings on Deck: What Surprise Awaits Investors?

BUD's fourth-quarter 2024 results are likely to show the impacts of challenging macroeconomic conditions and higher expenses.

Zacks Equity Research

Seeking Clues to Anheuser-Busch Inbev (BUD) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Evaluate the expected performance of Anheuser-Busch Inbev (BUD) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

KNBWY or BUD: Which Is the Better Value Stock Right Now?

KNBWY vs. BUD: Which Stock Is the Better Value Option?

Zacks Equity Research

New Strong Sell Stocks for January 22nd

AEO, BUD and ARCAY have been added to the Zacks Rank #5 (Strong Sell) List on January 22, 2025.

Zacks Equity Research

AB InBev Set to Brew Pabst Beer: What Does it Mean for BUD Stock?

AB InBev partners to brew beer for Pabst in its breweries. This marks a significant step for AB InBev to integrate a former competitor into its supply chain.

Zacks Equity Research

AB InBev Trades Below 200 & 50-Day SMAs: How to Play the Stock?

BUD stock continues its downtrend due to ongoing cost headwinds. However, its focus on premiumization and the Beyond Beer portfolio offers growth potential.

Zacks Equity Research

The Zacks Analyst Blog Highlights Vita Coco, Constellation Brands, Coca-Cola, Anheuser-Busch InBev and Keurig Dr Pepper

Vita Coco, Constellation Brands, Coca-Cola, Anheuser-Busch InBev and Keurig Dr Pepper are included in this Analyst Blog.

Rajani Lohia headshot

Raise a Toast: 5 Must-Watch Beverage Stocks Before the 2025 Countdown

As 2025 approaches, COCO, STZ, KO, BUD and KDP stand out as top picks for a profitable future, with various options from non-alcoholic drinks to premium spirits.